However, whether PPAR-γ agonists can exerta beneficial effect on soluble adhesion molecule levels to promote adhesion andtransendothelial migration of monocytes to endothelium in patients withdiabetes and CAD after percutaneous coronary intervention (PCI) is unknown. Here, PPARG is linked to coronary artery disorder.